NCT04568460

Brief Summary

The investigators propose the Standing Tall study, a prospective randomised study of strategy to optimize community-based ART initiation in South Africa. Investigators will work closely with community members to integrate community-based ART. One hundred participants will be enrolled and followed for a total of up to 6 months. Those in the intervention arm will be provided with the ST intervention which includes a behavioral component and access to ART. The intervention will be linked to a clinic through a "Nurse Initiated Management of ART."

Trial Health

58
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for phase_2 hiv

Timeline
Completed

Started Nov 2020

Typical duration for phase_2 hiv

Geographic Reach
2 countries

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 29, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

November 25, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

March 18, 2024

Status Verified

March 1, 2024

Enrollment Period

3.3 years

First QC Date

August 12, 2020

Last Update Submit

March 14, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • ART Initiation

    ART initiation will be assessed via a self-report measure of participants who will report whether they have or have not initiated ART.

    Three Months

  • ART Initiation

    ART initiation will also be assessed via a point-of-care diagnostic detecting Tenofovir concentrations in participants.

    Three Months

  • ART Initiation

    ART initiation will be assessed via a self-report measure of participants who will report whether they have or have not initiated ART.

    Six months

  • ART Initiation

    ART initiation will also be assessed via a point-of-care diagnostic detecting Tenofovir concentrations in participants.

    Six months

Secondary Outcomes (10)

  • Viral Load Suppression

    Six Months

  • Household Food Security

    Six Months

  • Mental Health

    Six Months

  • Substance Use

    Six Months

  • Wellness

    Six Months

  • +5 more secondary outcomes

Study Arms (2)

Intervention Group Sessions

EXPERIMENTAL

Intervention group sessions will be delivered by lay health counselors. The sessions will reflect principles of co-learning, participatory design, and empowerment to promote engagement of young people in critical thinking and problem solving - including modeling, roleplaying, and interactive activities.

Other: Intervention Group Sessions

Standard of Care

NO INTERVENTION

This is the standard of care arm. Participants newly diagnosed with HIV will get a referral to the local primary health care setting of their choice for further management, including ART.

Interventions

Participants will undergo a multi-session group intervention over the course of six months.

Also known as: Yima Nkqo
Intervention Group Sessions

Eligibility Criteria

Age18 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Complete an assessment of understanding
  • Provide informed consent
  • Are between ages 18-24
  • Present to Tutu Tester vans in Cape Town OR East London DTHF clinics (Duncan Village Day Hospital, Empilweni Gompo Health Centre, Gompo C Clinic) and test HIV+
  • Are ART-naïve
  • Are English or isiXhosa speakers
  • Reside in the Cape Town or East London metro area

You may not qualify if:

  • Are pregnant (must be referred to antenatal clinic if living with HIV)
  • Test positive for tuberculosis (must be referred to clinic for TB treatment prior to ART initiation)
  • Are unable to understand the process of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Desmond Tutu Health Foundation

East London, Eastern Cape, South Africa

Location

Desmond Tutu Health Foundation

Cape Town, Western Cape, South Africa

Location

Related Publications (2)

  • Bondarchuk CP, Lemon T, Medina-Marino A, Rousseau E, Sindelo S, Sibanda N, Butler LM, Bekker LG, Earnshaw VA, Katz IT. A Moderated Mediation Model of HIV-Related Anticipated Stigma and Social Capital on the Relationship Between Diagnosis During the COVID-19 Pandemic and Potentially Problematic Substance Use Among Young South Africans. Int J Behav Med. 2025 Nov 18. doi: 10.1007/s12529-025-10415-5. Online ahead of print.

  • Nardell MF, Sindelo S, Rousseau E, Siko N, Fuzile P, Julies R, Bassett IV, Mellins CA, Bekker LG, Butler LM, Katz IT. Development of "Yima Nkqo," a community-based, peer group intervention to support treatment initiation for young adults with HIV in South Africa. PLoS One. 2023 Jun 15;18(6):e0280895. doi: 10.1371/journal.pone.0280895. eCollection 2023.

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 12, 2020

First Posted

September 29, 2020

Study Start

November 25, 2020

Primary Completion

March 31, 2024

Study Completion

March 31, 2024

Last Updated

March 18, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations